0001104659-24-072815.txt : 20240618 0001104659-24-072815.hdr.sgml : 20240618 20240618161521 ACCESSION NUMBER: 0001104659-24-072815 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240617 FILED AS OF DATE: 20240618 DATE AS OF CHANGE: 20240618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scodari Joseph C CENTRAL INDEX KEY: 0001319892 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40536 FILM NUMBER: 241051959 MAIL ADDRESS: STREET 1: JOHNSON & JOHNSON STREET 2: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acurx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001736243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 259 LIBERTY AVENUE CITY: STATEN ISLAND STATE: NY ZIP: 10305 BUSINESS PHONE: 917-533-1469 MAIL ADDRESS: STREET 1: 259 LIBERTY AVENUE CITY: STATEN ISLAND STATE: NY ZIP: 10305 FORMER COMPANY: FORMER CONFORMED NAME: Acurx Pharmaceuticals, LLC DATE OF NAME CHANGE: 20180402 4 1 tm2417510-5_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-06-17 0 0001736243 Acurx Pharmaceuticals, Inc. ACXP 0001319892 Scodari Joseph C C/O ACURX PHARMACEUTICALS, INC., 259 LIBERTY AVENUE STATEN ISLAND NY 10305 1 0 0 0 0 Stock Option 2.38 2024-06-17 4 A 0 12000 0 A 2034-06-17 Common Stock 12000 12000 D This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on June 17, 2025. /s/ Kostantinos Skordalos, Power of Attorney For: Joseph C. Scodari 2024-06-18